Enoxaparin is a common low-molecular-weight heparin (LMWH) used in the prevention and management of various thromboembolic disorders. Initially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies. Enoxaparin markedly reduces the incidence of venous thromboembolism in hospitalized patients when compared to unfractionated heparin, without increasing the risk of serious bleeding.
Enoxaparin is indicated for the prevention of ischemic complications in unstable angina and in non Q-wave myocardial infarction; it is indicated in conjunction with percutaneous intervention and/or other treatment for the management of acute ST elevation myocardial infarction.
Enoxaparin is also indicated in the prophylaxis of DVT in abdominal surgery, hip replacement, knee replacement, or medical patients with severely restricted mobility during acute illness. Additionally, enoxaparin is indicated for the inpatient treatment of DVT with or without pulmonary embolism and the treatment of outpatient DVT without pulmonary embolism.
Prof. A. Gruca Teaching Hospital, The Medical Centre of Postgraduate Education, Otwock, Woj. Mazowieckie, Poland
First site in, Madrid, Spain
Third site in, Madrid, Spain
Bad Friedrichshall, Heilbronn, Germany
Long Beach Memorial Care Center for Women at Miller Children's Hospital Long Beach and Long Beach Memorial Hospital, Long Beach, California, United States
Department of Nephrology and Hypertension, Meir Medical Center, Kfar Sava, Israel
Helsinki committee, Kfar Sava, Israel
Stanford University School of Medicine, Stanford, California, United States
KUleuven/UZ Gasthuisberg, Leuven, Belgium
St. Petersburg State Public Health Institution "City Multi-field Hospital #2", Saint-Petersburg, Russian Federation
State Budget Public Health Institution of Yaroslavl region "Clinical hospital #10", Municipal Clinical Public Health Institution " Medical Unit of Novo-Yaroslavl Petroleum Refinery", Yaroslavl, Russian Federation
State Budget Public Health Institution of Yaroslavl Region "Regional Clinical Hospital", Yaroslavl, Russian Federation
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
Lahey Clinic, Burlington, Massachusetts, United States
Grady Memorial Hospital, Atlanta, Georgia, United States
New York Presbyterian Hospital, New York, New York, United States
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
Memorial Sloan Kettering West Harrison, Harrison, New York, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.